Various mitochondrial proteins, dehydrogenases, ion channels, and solute transporters

This target designation refers to a broad and heterogeneous group of proteins located within or associated with the mitochondria, including enzymes (dehydrogenases), ion-conducting pores (ion channels), and carrier proteins (solute transporters). These proteins collectively regulate essential cellular processes such as the citric acid cycle, oxidative phosphorylation, ion homeostasis, and the transport of metabolites across the mitochondrial membranes. Dehydrogenases like NADH dehydrogenase (Complex I) and mitochondrial glycerophosphate dehydrogenase are critical for electron transport and redox balance. Ion channels, such as the voltage-dependent anion channel (VDAC), and solute transporters, such as the mitochondrial pyruvate carrier (MPC), facilitate the movement of ions and metabolites necessary for energy production. Drugs that interact with this diverse set of targets, such as biguanides (e.g., metformin) and thiazolidinediones (e.g., glitazones), often exert pleiotropic effects by modulating mitochondrial energy production and cellular signaling pathways. While targeting these proteins can be therapeutically beneficial for metabolic disorders like Type 2 diabetes or certain cancers, non-specific interactions can lead to significant safety concerns. Notable risks include mitochondrial dysfunction, lactic acidosis, and potential cardiotoxicity due to off-target binding in high-energy tissues. The complexity of this target reflects the integrated nature of mitochondrial metabolism and its central role in both health and disease.

Other names

Mitochondrial proteomeMitochondrial membrane proteinsMitochondrial off-targetsPleiotropic mitochondrial targets

Inhibition of mitochondrial respiration (e.g., Complex I), modulation of ion flux (e.g., VDAC), and regulation of metabolite transport (e.g., MPC and OCTs).